HOME >> MEDICINE >> NEWS
Bayer launches Phase III clinical study of Trasylol in elective spinal fusion surgery

Bayer Pharmaceuticals Corporation (NYSE: BAY) today announced the initiation of a Phase III clinical trial to evaluate the safety and efficacy of Trasylol (aprotinin injection) in reducing blood loss and the need for transfusion in adult patients undergoing elective spinal fusion surgery.

Spinal fusion surgery involves 'fusing' together one or more of the small bones of the spine with bone grafts and devices. This fusion limits the motion between the vertebrae allowing surgeons to treat injuries to the spine, repair broken vertebra, correct deformities, adjust abnormal curvatures, stabilize weakness and remedy slipped or herniated disks. Approximately 300,000 spinal fusion surgeries take place each year in the United States, a figure that has doubled in the last decade (1).

Patients undergoing spinal fusion surgery are subject to a blood transfusion rate that may be six times greater than that of patients undergoing spinal surgery without fusion (2). Spine fusion surgery is also associated with more complications (such as infection, chronic pain and neural injuries) as it requires more extensive dissection and longer operative time (3).

"Blood loss can be a significant complication of spine surgery. Combined with the potential health risks associated with transfusions and the rising cost of blood products, there is a great need to reduce bleeding in this surgical setting," said Michael Neuwirth, MD, lead investigator of the study and director of the Spine Institute at Beth Israel Medical Center. "Trasylol has been proven safe and effective in reducing blood loss and transfusion requirements in coronary artery bypass surgery, and we are studying the drug to determine if it may play a similar role in spinal fusion surgery."

The multi-center, randomized, double-blind, placebo-controlled trial will assess the ability of Trasylol to reduce bleeding and the need for blood transfusions in elective spinal fusion surgery involving three
'"/>


8-Dec-2005


Page: 1 2

Related medicine news :

1. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
2. Worlds largest respiratory health study launches next phase
3. Elsevier launches the Clinics on ScienceDirect
4. Elsevier launches Molecular Oncology
5. Kennedy Krieger Institute launches first national online autism registry
6. UW launches study testing adult stem cells for heart damage repair
7. IEEE-USA launches critical infrastructure protection committee
8. Liverpool launches 20 million project to develop medicines for children
9. ESSP launches project on the effects of global environmental change on human health
10. ACP re-launches magazine for hospitalists
11. The Starr Foundation launches multi-institutional cancer consortium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... A July 26 article ... should be brushing their pets’ teeth twice a day. The acknowledges that, with dogs ... and suggests that close monitoring and brushing at least twice a week is likely ...
(Date:8/19/2019)... ... August 18, 2019 , ... ... its third product, Aqua+, adding two SKUs to its line of functional offerings. ... more effectively than water alone. Distinguishing Aqua+ from other rehydration solutions is the ...
(Date:8/17/2019)... ... August 17, 2019 , ... Inc. Magazine ... Companies—the Inc. 5000 , For the 2nd Year In a Row, YellowTelescope LLC ... 192% Percent , Inc. magazine today revealed that YellowTelescope LLC (YellowTelescope, SEOversite, and ...
(Date:8/16/2019)... LOS ANGELES (PRWEB) , ... August 16, 2019 ... ... seeking to revolutionize and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the ... world, is set to launch its crowdfunding campaign to raise $50 million on ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House Charities in New Hyde Park, ... residents undergoing medical treatments and their family members a comfortable and fun way ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... The ... Bend Emergency Physicians (SBEP) of Indiana as a member group. , SBEP is ... South Bend. , SBEP sought out the AAEM-PG for administrative and practice ...
(Date:8/16/2019)... ... August 16, 2019 , ... Quantum ... could potentially treat treatment-resistant hypertension by acting in the brain to interfere with ... people worldwide that are affected by treatment-resistant hypertension, resulting in almost 10 million ...
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... (IT) Innovator, Tricia Lee (Wilkins) Rolle, PharmD, PhD, has joined the company as ... work with public and private sectors and industry standards organizations to advance use ...
Breaking Medicine Technology:
Cached News: